| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 04/28/2005 | US20050090525 carboxymethylated N-(nitrogen group functionalized alkyl- carbonylhydrazido)- or carbonylaminomethylcarbonyl)- substituted; integrin inhibitors used for combating thromboses, cardiac infarction, coronary heart diseases, arteriosclerosis, inflammation, tumors, osteoporosis, infections and restenosis |
| 04/28/2005 | US20050090524 Novel adamantane derivatives |
| 04/28/2005 | US20050090517 Pharmaceutical combinations of cox-2 inhibitors and opiates |
| 04/28/2005 | US20050090502 Protein tyrosine phosphatase 1B inhibitors alone or incombination with other antidiabetic, antilipemic, anticholesterol or hypotensive agents |
| 04/28/2005 | US20050090501 Heteroaryl-cyclic acetals |
| 04/28/2005 | US20050090494 Such as N-[2-(3-{[1-(3,4-dichlorobenzylpiperidinyl]aminohydroxypropoxy)phenyl]acetamide; antiinflammatory agents, antiarthritic agents; chronic obstructive pulmonary disease, asthma, multiple sclerosis |
| 04/28/2005 | US20050090493 Useful as anti-cancer agents; exhibit apoptotic effect in a warm-blooded animal such as man; for example, 2-{4-[3-(N,N-Dimethyl)amino-2-hydroxy-propoxy]anilino}-4-(2,4-difluoro-(N-cyanomethyl)anilino)pyrimidine |
| 04/28/2005 | US20050090491 2'-Methyl-5'-(1,3,4-oxadiazol-2-yl)-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/28/2005 | US20050090487 Cardiovascular disorders; antiinflammatory agents |
| 04/28/2005 | US20050090472 Xanthine oxidase inhibitors |
| 04/28/2005 | US20050090466 Inhibitors of PACE4 for the treatment of arthritis |
| 04/28/2005 | US20050090457 Method of treating mammals with genistein and/or genistein analogues |
| 04/28/2005 | US20050089933 Compositions and methods for surrogate antibody modulation of an immune response and transport |
| 04/28/2005 | US20050089911 87 human secreted proteins |
| 04/28/2005 | US20050089578 Methods and devices for tissue repair |
| 04/28/2005 | US20050089573 Oral pharmaceutical formulation containing ibandronate |
| 04/28/2005 | US20050089559 Flupirtine in combination with tolperisone or its analogs, such as eperisone or silperisone; pains which are accompanied by an increase in muscle tone such as neuralgia |
| 04/28/2005 | US20050089522 Treating a bone cancer patient with a monoclonal antibody that specifically binds a RANK (receptor activator of NF- kappa B) polypeptide with specific amino acid sequence for inhibiting RANK-induced osteoclastogenesis |
| 04/28/2005 | US20050089520 Antibody stimulating il-ira production |
| 04/28/2005 | US20050089510 Immunization against plaque forming diseases such as cardiovascular disorders with vaccines for disaggregation |
| 04/28/2005 | CA2543406A1 Mutants of human chondromodulin-i (hchm-i) and uses thereof in inhibiting angiogenesis and bone resorption |
| 04/28/2005 | CA2542395A1 Treatment of arthritic conditions, chronic inflammation or pain |
| 04/28/2005 | CA2542290A1 Substituted 2-amino-[1,2,4]triazolo[1,5-a]pyrimidine derivative and use thereof |
| 04/27/2005 | EP1526133A1 Epothilone derivatives |
| 04/27/2005 | EP1526132A2 Substituted oxazolidinone derivatives and their use as factor xa inhibitors |
| 04/27/2005 | EP1525883A1 Ciclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 04/27/2005 | EP1525307A2 Modified adamts4 molecules and method of use thereof |
| 04/27/2005 | EP1525306A1 Three-dimensional structure of dipeptidyl peptidase iv |
| 04/27/2005 | EP1525204A1 Phenylalanine enamide derivatives |
| 04/27/2005 | EP1525201A1 Bicyclic piperidine derivatives as antagonists of the ccr1 chemokine receptor |
| 04/27/2005 | EP1525200A1 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors |
| 04/27/2005 | EP1525199A1 Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors |
| 04/27/2005 | EP1525191A2 Novel method for preparing styryl pyrazole, isoxazole and isothiazole derivatives |
| 04/27/2005 | EP1525030A1 Combination of an allosteric alkyne inhibitor of matrix metalloproteinase-13 with a selective inhibitor of cyclooxygenase-2 that is not celecoxib or valdecoxib |
| 04/27/2005 | EP1524997A1 Stable liquid parenteral parecoxib formulation |
| 04/27/2005 | EP1524980A1 Phenylalanine enamide derivatives containing a spiro[3.5]non-1-ene ring for use as integrin inhibitors |
| 04/27/2005 | EP1524974A2 Transcription factor modulating compounds and methods of use thereof |
| 04/27/2005 | EP1419150B1 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use |
| 04/27/2005 | EP1289519A4 Methods of treating androgen deficiency in men using selective antiestrogens |
| 04/27/2005 | EP1040098B1 Integrin receptor antagonists |
| 04/27/2005 | EP0994853B1 A monoether of probucol and methods for the inhibition of the expression of vcam-1 |
| 04/27/2005 | EP0906307B1 Substituted imidazoles having cytokine inhibitory activity |
| 04/27/2005 | EP0850068B1 Lipid extract having anti-inflammatory activity |
| 04/27/2005 | EP0833651B1 Analgesic use of n-l-alpha-aspartyl-l-phenylalanine 1-methyl ester |
| 04/27/2005 | CN1610751A Method for measuring serine palmitoyltransferase in mammalian tissue and use thereof |
| 04/27/2005 | CN1610674A Use of 2-amino-thiazoline derivatives as inhibitors of inducible NO-synthase |
| 04/27/2005 | CN1610661A Allenic aryl sulfonamide hydroxamic acids as matrix metalloproteinase and TACE inhibitors |
| 04/27/2005 | CN1610502A Surfactant protein for the prevention and diagnosis of pulmonary emphysema |
| 04/27/2005 | CN1608666A Fracture setting Chinese medicine and its prepn process |
| 04/27/2005 | CN1608513A Health food containing hyaluronic acid and dermatan sulfate |
| 04/27/2005 | CN1198818C Compound with growth hormone releasing properties |
| 04/27/2005 | CN1198804C Amide compounds and use thereof |
| 04/27/2005 | CN1198802C Chalcones having antiproliferactive activity |
| 04/27/2005 | CN1198647C Antibodies against human CD40 |
| 04/27/2005 | CN1198646C Identification of unique binding interactions between certain antibodies and the human B7.1 and B7.2 co-stimulatory antigens |
| 04/27/2005 | CN1198634C Chinese medicine prepn for treating cervical spondylopathy and its prepn process |
| 04/27/2005 | CN1198628C Conditioned cell culture medium compositions and method of use |
| 04/27/2005 | CN1198625C Pharmaceutical compositions for treatment of mucositis, stomatitis and Behchet's syndrome |
| 04/27/2005 | CN1198614C Method for treating inflammatory diseases using pADPRT inhibitors |
| 04/27/2005 | CN1198589C Method for controlling liposome size |
| 04/27/2005 | CN1198586C Topical compositions for NSAI drug delivery |
| 04/26/2005 | US6884804 Inhibitors of Src and other protein kinases |
| 04/26/2005 | US6884802 Phenanthridines substituted in position 6 by a mono, bi- or tricyclic heteroaryl radical; cyclic nucleotidephosphoesterase (PDE4) inhibitor and useful for treating respiratory system disorders |
| 04/26/2005 | US6884800 Nitrogen compounds such as 10-Chloro-3-imidazol-1-yl-2,3-dihydro-1H-pyrido(3,2,1-kl)phenothiazine, used for prophylaxis of respiratory system and skin disorders, autoimune diseases, tumors or atherosclerosis and AIDS |
| 04/26/2005 | US6884795 Pharmaceutical compositions and uses for androst-5-ene-3β, 17β-diol |
| 04/26/2005 | US6884574 Methods of identifying agents which inhibit GPR-9-6 |
| 04/26/2005 | US6884413 Immunosuppressants for organ transplantions by inducing apoptosis/anergy in T cells; genetic engineering; antigen presenting cells |
| 04/21/2005 | WO2005035534A1 Heterocyclic bicyclo ring and heterocyclic tricyclo ring compounds and drugs comprising the same |
| 04/21/2005 | WO2005035516A1 Novel fused heterocyclic compound and use thereof |
| 04/21/2005 | WO2005035503A1 Novel isoquinoline derivative |
| 04/21/2005 | WO2005035498A1 Use of nitrogenous bicyclic compound as feeding control agent |
| 04/21/2005 | WO2005034965A1 Use of hyaluronic acid for treating sprain and strain |
| 04/21/2005 | WO2005034945A1 Use of norphenazone and coenzyme q for curing arthrose, arthritis and osteoarthritis |
| 04/21/2005 | WO2005034937A1 Composition for treatment of osteoarthritis containing apigenin as chindroregenerative agent |
| 04/21/2005 | WO2005034838A2 Protease inhibitors |
| 04/21/2005 | WO2005020965A3 Skeletally targeted nanoparticles |
| 04/21/2005 | WO2005011721A3 Use of a pak inhibitor for the treatment of a joint disease |
| 04/21/2005 | WO2005010047A3 Antiangiogenic compounds, pharmaceutical composition containing said compounds and the use thereof |
| 04/21/2005 | WO2004098582A3 Ketones and reduced ketones as therapeutic agents for the treatment of bone conditions |
| 04/21/2005 | WO2004078169A8 Use of ep2 selective receptor agonists in medical treatment |
| 04/21/2005 | WO2004005313A3 Hybrid molecules of macrolides with steroid/non-steroid anti-inflammatory, antineoplastic and antiviral active molecules |
| 04/21/2005 | WO2003049673A3 Methods and compositions for control of bone formation via modulation of sympathetic tone |
| 04/21/2005 | US20050085667 N-biphenylmethyl aminocycloalkanecarboxamide derivatives |
| 04/21/2005 | US20050085543 Genetic engineering; wound healing agents |
| 04/21/2005 | US20050085541 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof |
| 04/21/2005 | US20050085519 Controlling cell differentiation, cell proliferation; anticancer agents |
| 04/21/2005 | US20050085509 KInase inhibitors; antiarthritic agents; autoimmune diseases; sepsis; cachexia; Alzheimer's disease; antihistamines; thrombosis; glomerulonephritis; inflammatory bowel disorders; crohn's disese; multiple sclerosis; antitumor agents; skin disorders |
| 04/21/2005 | US20050085487 Heterocyclic compounds |
| 04/21/2005 | US20050085480 Water-soluble phenylpyridazine compounds and compositions containing the same |
| 04/21/2005 | US20050085469 Fused bicyclic pyrimidine derivatives |
| 04/21/2005 | US20050085456 Compounds useful in therapy |
| 04/21/2005 | US20050085423 Administering an amide ciompound ; analgesics; antiinflamamtory agents |
| 04/21/2005 | US20050085418 Ligands for TGF-beta binding proteins and uses thereof |
| 04/21/2005 | US20050084897 DNA encoding human vanilloid receptor VR3 |
| 04/21/2005 | US20050084518 For producing beautiful skin and improving constipation, reducing hair loss |
| 04/21/2005 | US20050084489 Synergistic administration of Vitaxin, a FAB fragment, or a competitive binding antibody for binding integrin alpha V beta 3 with the enzyme inhibitor; antiinflammatory, anticarcinogenic agents; autoimmune and metabolic bone disorders |
| 04/21/2005 | US20050084482 As an antiinflammatory agent for gastrointestinal inflammation involved with inflammatory bowel disease or irritable bowel syndrome |
| 04/21/2005 | US20050084463 Antiinflammatory, antiarthritic agents, analgesics for pain caused by diabetic assoicated conditions, pneumoconiosis, angina, menstruation or cancer |
| 04/21/2005 | CA2548578A1 Composition for treatment of osteoarthritis containing apigenin as chondroregenerative agent |
| 04/20/2005 | EP1523982A2 Plenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders |